Perrigo Company plc Ordinary Shares (PRGO)
Stock · NYSE · Health Care
$16.63as of 10/16/2026
Price chart
Active signals
PRGO Signal Track Record
How signals performed across all stocks →What PRGO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 32 | -1.4% | 44% | September 18, 2026 |
| Bollinger Band Breakdown | 24 | +0.4% | 50% | June 17, 2026 |
| 200-Day Moving Average TouchActive now | 23 | -3.3% | 30% | June 5, 2025 |
| Bollinger Band BreakoutActive now | 18 | -4.4% | 28% | September 25, 2026 |
| Any 20-session window (baseline) | -0.4% | 48% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PRGO
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverag…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 8,100
- Website
- www.perrigo.com/
Fundamentals
- 1-day range
- $16.26$16.68
- Market cap
- $1.74B
- P/E (trailing)
- —
- P/E (forward)
- 6.93
- EPS (trailing)
- $-12.59
- Dividend yield
- 3.54%
- Beta
- 0.71
- Avg. volume
- 2.82M
- Ex-dividend date
- August 28, 2026
- Dividend pay date
- September 15, 2026
How Perrigo Company plc Ordinary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Perrigo Company plc Ordinary Shares Competitors
Chosen by industry and closest market cap.
- PRGOPerrigo Company plc Ordinary Shares$16.63▲ 0.91%Market cap $1.74BP/E —$9.23$22.02
- SNDXSyndax Pharmaceuticals Inc. Common Stock$12.9▼ 5.49%Market cap $1.76BP/E —$12.99$25.59
- SRPTSarepta Therapeutics Inc. Common Stock (DE)$17.1▼ 3.88%Market cap $1.77BP/E —$14.68$24.68
- GENBGenerate Biomedicines Inc. Common Stock$12.09▼ 7.43%Market cap $1.78BP/E —$11$22.67
- ZYMEZymeworks Inc. Common Stock$25.03▼ 2.80%Market cap $1.69BP/E —$16$31.34
- SEPNSepterna Inc. Common Stock$36.35▼ 2.94%Market cap $1.78BP/E —$17.55$51.1
- KARDKardigan Inc. Common Stock$13.03▼ 6.12%Market cap $1.79BP/E —$12.23$27
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PRGO Perrigo Company plc Ordinary Shares | $1.74B | — | $16.63 | ▲ 0.91% | $9.23$22.02 |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | $1.76B | — | $12.9 | ▼ 5.49% | $12.99$25.59 |
| SRPT Sarepta Therapeutics Inc. Common Stock (DE) | $1.77B | — | $17.1 | ▼ 3.88% | $14.68$24.68 |
| GENB Generate Biomedicines Inc. Common Stock | $1.78B | — | $12.09 | ▼ 7.43% | $11$22.67 |
| ZYME Zymeworks Inc. Common Stock | $1.69B | — | $25.03 | ▼ 2.80% | $16$31.34 |
| SEPN Septerna Inc. Common Stock | $1.78B | — | $36.35 | ▼ 2.94% | $17.55$51.1 |
| KARD Kardigan Inc. Common Stock | $1.79B | — | $13.03 | ▼ 6.12% | $12.23$27 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?Yahoo · 9/25/2026
- Dividend Champion, Contender, And Challenger Highlights: Week September 13SeekingAlpha · 9/11/2026
Insider Activity
Insider Actions →- Geoffrey M. Parker · September 11, 2026 · Option Exercise1.3K @ $13.66
- Geoffrey M. Parker · September 11, 2026 · Tax Withholding607 @ $13.66
- Bradley A. Alford · September 11, 2026 · Grant2.1K
- Bradley A. Alford · September 11, 2026 · Option Exercise1.3K @ $13.66
- Bradley A. Alford · September 11, 2026 · Tax Withholding607 @ $13.66
- Ball David · September 9, 2026 · Option Exercise7.7K @ $14.34
- Ball David · September 9, 2026 · Tax Withholding2.8K @ $14.34
- Winterman Matthew John · July 8, 2026 · Tax Withholding963 @ $10.52
- Winterman Matthew John · July 8, 2026 · Tax Withholding8.2K @ $10.52
- Khoury Roberto · July 8, 2026 · Option Exercise737 @ $10.52
- Khoury Roberto · July 8, 2026 · Tax Withholding385 @ $10.52
- Winterman Matthew John · July 8, 2026 · Option Exercise15.7K @ $10.52
- Amin Ahmed Salman · July 8, 2026 · Grant15.0K
- Gajial Muhammad Omer · July 8, 2026 · Grant15.0K
- Manzone Albert · July 8, 2026 · Grant235.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Perrigo valuation seen as cheap but burdened by high debt
A recent Seeking Alpha article notes that Perrigo's shares appear cheap compared with peers. The piece highlights that the company carries a sizable debt load, which could limit financial flexibility. This contrast may lead investors to weigh the low valuation against the debt risk when evaluating the company.
Perrigo valuation seen as cheap but burdened by high debt. A recent Seeking Alpha article notes that Perrigo's shares appear cheap compared with peers. The piece highlights that the company carries a sizable debt load, which could limit financial flexibility. This contrast may lead investors to weigh the low valuation against the debt risk when evaluating the company.